INS and Alzheimer disease: The safety of using KD in AD patients was further described, with another study utilizing a KD supplemented with medium-chain triglycerides (MCTs) noting MCT-associated diarrhea in 50% of patients, but reporting no changes in blood glucose levels, insulin, liver function tests, renal functioning, electrolyte balances, body mass index, bone mass or EKG, concluding the safety of this high-fat diet in AD for at least 3 months (Taylor et al., 2018).